Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Interest Expense : ¥-22 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hubei Jumpcan Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ¥ -8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-22 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hubei Jumpcan Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ¥ 720 Mil. Hubei Jumpcan Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -8 Mil. Hubei Jumpcan Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 95.31. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hubei Jumpcan Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Interest Expense Chart

Hubei Jumpcan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-30.74

-33.03

-34.90

-30.41

-17.58

Hubei Jumpcan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-2.93	-3.63	-3.43	-7.60	-7.55

Hubei Jumpcan Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-22 Mil.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hubei Jumpcan Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥-8 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥720 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥1 Mil.

Hubei Jumpcan Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	719.706	/	-7.551
	=	95.31

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hubei Jumpcan Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN

Website

http://www.jumpcan.com

Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Executives

Cao Wei	Directors, senior managers
Zhou Qi Hua	senior management
Huang Qu Rong	Director
Yan Hong Quan	senior management
Shi Wen Zheng	senior management
Zhang Jian Min	Director
Cao Long Xiang	Director
Yan Yue Hua	Director

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines